Area of research
Hematology · Genetics
Research interest
Research interests include Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, and Acute Lymphoblastic Leukemia research.
The evolution of treatment-free remission
Impact of <i>ASXL1</i> at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.
Flow cytometric detection of BCR::ABL1 in T-lymphocytes in chronic myeloid leukaemia.
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study
Predicting treatment-free remission outcomes in Chronic Myeloid Leukemia patients using an integrated model of tumor-immune dynamics
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia.
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia.
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells.
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia.
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies
Secondary solid cancer screening following hematopoietic cell transplantation